Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Sponsor: Regeneron Pharmaceuticals
Summary
The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major congenital malformations \[MCMs\], small for gestational age \[SGA\]) in women with AD who are treated with dupilumab during pregnancy relative to women with AD who are not treated with dupilumab during pregnancy.
Official title: Dupilumab and Pregnancy Outcomes: A Retrospective Cohort Study Using Administrative Healthcare Databases (Dupi PODS)
Key Details
Gender
FEMALE
Age Range
18 Years - 49 Years
Study Type
OBSERVATIONAL
Enrollment
3930
Start Date
2019-09-30
Completion Date
2027-01-21
Last Updated
2025-08-03
Healthy Volunteers
No
Interventions
dupilumab
No study drug will be administered. This study is based on an analysis of automated medical and prescription claims, supplemented by information abstracted from the medical record.
Locations (1)
Regeneron Research Site
Boston, Massachusetts, United States